Diaphragm adaptations in patients with COPD
- PMID: 18218129
- PMCID: PMC2248576
- DOI: 10.1186/1465-9921-9-12
Diaphragm adaptations in patients with COPD
Abstract
Inspiratory muscle weakness in patients with COPD is of major clinical relevance. For instance, maximum inspiratory pressure generation is an independent determinant of survival in severe COPD. Traditionally, inspiratory muscle weakness has been ascribed to hyperinflation-induced diaphragm shortening. However, more recently, invasive evaluation of diaphragm contractile function, structure, and biochemistry demonstrated that cellular and molecular alterations occur, of which several can be considered pathologic of nature. Whereas the fiber type shift towards oxidative type I fibers in COPD diaphragm is regarded beneficial, rendering the overloaded diaphragm more resistant to fatigue, the reduction of diaphragm fiber force generation in vitro likely contributes to diaphragm weakness. The reduced diaphragm force generation at single fiber level is associated with loss of myosin content in these fibers. Moreover, the diaphragm in COPD is exposed to oxidative stress and sarcomeric injury. This review postulates that the oxidative stress and sarcomeric injury activate proteolytic machinery, leading to contractile protein wasting and, consequently, loss of force generating capacity of diaphragm fibers in patients with COPD. Interestingly, several of these presumed pathologic alterations are already present early in the course of the disease (GOLD I/II), although these patients appear not limited in their daily life activities. Treatment of diaphragm dysfunction in COPD is complex since its etiology is unclear, but recent findings indicate the ubiquitin-proteasome pathway as a prime target to attenuate diaphragm wasting in COPD.
Figures





Similar articles
-
Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept.Am J Respir Crit Care Med. 2007 Jun 15;175(12):1233-40. doi: 10.1164/rccm.200701-020PP. Epub 2007 Apr 5. Am J Respir Crit Care Med. 2007. PMID: 17413128 Review.
-
Diaphragm dysfunction in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2005 Jul 15;172(2):200-5. doi: 10.1164/rccm.200502-262OC. Epub 2005 Apr 22. Am J Respir Crit Care Med. 2005. PMID: 15849324 Free PMC article.
-
Respiratory muscle dysfunction in COPD: from muscles to cell.Curr Drug Targets. 2011 Apr;12(4):478-88. doi: 10.2174/138945011794751474. Curr Drug Targets. 2011. PMID: 21194407 Review.
-
Proteasome inhibition improves diaphragm function in an animal model for COPD.Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L110-6. doi: 10.1152/ajplung.00396.2010. Epub 2011 Apr 1. Am J Physiol Lung Cell Mol Physiol. 2011. PMID: 21460121
-
Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation?J Appl Physiol (1985). 2009 Jul;107(1):324-35. doi: 10.1152/japplphysiol.00173.2009. Epub 2009 Apr 9. J Appl Physiol (1985). 2009. PMID: 19359619 Free PMC article. Review.
Cited by
-
Endotoxin-Induced Emphysema Exacerbation: A Novel Model of Chronic Obstructive Pulmonary Disease Exacerbations Causing Cardiopulmonary Impairment and Diaphragm Dysfunction.Front Physiol. 2019 May 28;10:664. doi: 10.3389/fphys.2019.00664. eCollection 2019. Front Physiol. 2019. PMID: 31191356 Free PMC article.
-
Intraoperative Anesthetic Management of Patients with Chronic Obstructive Pulmonary Disease to Decrease the Risk of Postoperative Pulmonary Complications after Abdominal Surgery.J Clin Med. 2020 Jan 6;9(1):150. doi: 10.3390/jcm9010150. J Clin Med. 2020. PMID: 31935888 Free PMC article.
-
Leptin and Insulin in COPD: Unveiling the Metabolic-Inflammatory Axis-A Narrative Review.J Clin Med. 2025 Apr 10;14(8):2611. doi: 10.3390/jcm14082611. J Clin Med. 2025. PMID: 40283443 Free PMC article. Review.
-
The difference in the diaphragmatic physiological measures between inspiratory and expiratory phases in ALS.Neurol Sci. 2022 Dec;43(12):6821-6830. doi: 10.1007/s10072-022-06371-7. Epub 2022 Aug 30. Neurol Sci. 2022. PMID: 36042062
-
Manual Therapy Interventions in Patients With Chronic Obstructive Pulmonary Disease: A Comprehensive Narrative Review.Cureus. 2024 Jun 17;16(6):e62511. doi: 10.7759/cureus.62511. eCollection 2024 Jun. Cureus. 2024. PMID: 39022457 Free PMC article. Review.
References
-
- Begin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991;143:905–912. - PubMed
-
- Zielinski J, MacNee W, Wedzicha J, Ambrosino N, Braghiroli A, Dolensky J, Howard P, Gorzelak K, Lahdensuo A, Strom K, Tobiasz M, Weitzenblum E. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis. 1997;52:43–47. - PubMed
-
- Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:961–966. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical